coronary heart disease
Conditions
Interventions
indobufen:Indobufen and clopidogrel were used for antiplatelet therapy after CABG
Aspirin:Aspirin and clopidogrel were used for antiplatelet therapy after CABG
Sponsors
Taizhou hospital of Zhejiang Province
Eligibility
Sex/Gender
All
Age
39 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients were diagnosed with coronary heart disease and underwent coronary artery bypass grafting; (2) Saphenous vein and internal mammary artery were used as grafts. (3) patients without history of allergy to aspirin, clopidogrel and indobufen; (4) Aspirin was discontinued 5 to 7 days before surgery.
Exclusion criteria
Exclusion criteria: (1) complicated with serious organic diseases of other systems; (2) patients with coagulation dysfunction or bleeding tendency; (3) patients with malignant tumors; (4) atrial fibrillation (5) patients undergoing other types of cardiac surgery (such as valve replacement) at the same time; (6) other patients requiring anticoagulant drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| platelet count;hemoglobin;D-dimer;APTT;hospital stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| Transfusion rate; | — |
Countries
China
Contacts
Public ContactYu Ren
Taizhou hospital of Zhejiang Province
Outcome results
None listed